In a report released on July 22, from HSBC maintained a Hold rating on QuantumPharm, Inc., with a price target of HK$8.00. The company’s shares...
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for QuantumPharm, Inc. with a HK$9.81 average price target.
Based on QuantumPharm, Inc.’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of HK$280.78 million and a net profit of HK$40.27 million. In comparison, last year the company earned a revenue of HK$163.8 million and had a GAAP net loss of HK$279.59 million
J.P. Morgan analyst maintained a Buy rating on QuantumPharm, Inc. on July 23 and set a price target of HK$10.00. The company’s…
HSBC analyst maintained a Hold rating on Hygeia Healthcare Holdings Co., Ltd. on July 22 and set a price target of HK$10.50. The…
HSBC analyst maintained a Buy rating on CLP Holdings yesterday and set a price target of HK$86.00.4th of July Sale - 70% Off…
In a report released on July 1, from HSBC maintained a Hold rating on Estun Automation Co. Ltd. Class H, with a price target of…
In a report released on July 17, from Guggenheim reiterated a Hold rating on Quanta Services. The company’s shares closed last…
In a report released on May 15, from Bank of China maintained a Buy rating on Hua Hong Semiconductor Ltd., with a price target…
